Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Sep 19;370(1677):20140214.
doi: 10.1098/rstb.2014.0214.

The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people

Affiliations
Review

The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people

Barbara J Sahakian et al. Philos Trans R Soc Lond B Biol Sci. .

Abstract

In addition to causing distress and disability to the individual, neuropsychiatric disorders are also extremely expensive to society and governments. These disorders are both common and debilitating and impact on cognition, functionality and wellbeing. Cognitive enhancing drugs, such as cholinesterase inhibitors and methylphenidate, are used to treat cognitive dysfunction in Alzheimer's disease and attention deficit hyperactivity disorder, respectively. Other cognitive enhancers include specific computerized cognitive training and devices. An example of a novel form of cognitive enhancement using the technological advancement of a game on an iPad that also acts to increase motivation is presented. Cognitive enhancing drugs, such as methylphenidate and modafinil, which were developed as treatments, are increasingly being used by healthy people. Modafinil not only affects 'cold' cognition, but also improves 'hot' cognition, such as emotion recognition and task-related motivation. The lifestyle use of 'smart drugs' raises both safety concerns as well as ethical issues, including coercion and increasing disparity in society. As a society, we need to consider which forms of cognitive enhancement (e.g. pharmacological, exercise, lifelong learning) are acceptable and for which groups (e.g. military, doctors) under what conditions (e.g. war, shift work) and by what methods we would wish to improve and flourish.

Keywords: cognitive enhancers; cognitive training; game; neuroethics; schizophrenia; smart drugs.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Memory game training in schizophrenia: the cognitive training (CT) group made fewer errors (a), needed fewer trials to target (b) and correctly located more patterns at the first attempt (c) of the eight-pattern stage on the PAL task than the treatment as usual (TAU) group. The CT group indicated that they enjoyed playing the game and were motivated to continue across all hours of cognitive training (all ratings higher than 65%) (d).

Similar articles

Cited by

References

    1. Care Quality Commission. 2013. The safer management of controlled drugs: annual report 2012 See http://www.cqc.org.uk/sites/default/files/documents/cdar_2012.pdf (15.12.2014).
    1. Boseley S. 2014. £200,000 ‘smart’ drugs seizure prompts alarm over rising UK sales. The Guardian, London, Friday 24 October 2014.
    1. Presidential Commission for the Study of Bioethics. 2014. GRAY MATTERS: integrative approaches for neuroscience, ethics, and society See http://www.bioethics.gov/sites/default/files/Gray%20Matters%20Vol%201.pdf (29.11.2014).
    1. Maslen H, Faulmüller N, Savulescu J. 2014. Pharmacological cognitive enhancement—how future neuroscientific research could advance ethical debate. Front. Syst. Neurosci. 8, 107 (10.3389/fnsys.2014.00107) - DOI - PMC - PubMed
    1. Sahakian BJ. 2014. What do experts think we should do to achieve brain health? Neurosci. Biobehav. Rev. 43, 240–258. (10.1016/j.neubiorev.2014.04.002) - DOI - PubMed

Publication types

MeSH terms

Substances